liothyronine sodium
- Product NDC
- 71335-1671
- 11-digit product format
- 713351671
- Labeler code
- 71335
- Product ID
- 71335-1671_acdb9ae3-5c9f-4087-9456-4579c728ba49
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA091382
- Marketing category
- ANDA
- Marketing start
- 2019-11-28
- Marketing end
- 0000-00-00
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 50 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1671-1 | 71335167101 | 30 TABLET in 1 BOTTLE (71335-1671-1) | 30 tablet | 2019-11-28 | 0000-00-00 | No | No | Current |
| 71335-1671-2 | 71335167102 | 60 TABLET in 1 BOTTLE (71335-1671-2) | 60 tablet | 2019-11-28 | 0000-00-00 | No | No | Current |